⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

April 14, 2024Journal of VitreoRetinal Diseases

Long-Term Follow-up of Patients With Cytomegalovirus Retinitis Treated With a Ganciclovir Implant

Jonathan T. Caranfa Jay S. Duker

View Full Paper

Ask AI

Bookmark

Share

Abstract

To assess the long-term safety and clinical outcomes of a ganciclovir intravitreal implant in patients with cytomegalovirus (CMV) retinitis.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Caranfa et al. (2024) studied this question.

synapsesocial.com/papers/68e6f3b7b6db64358766ea88 https://doi.org/10.1177/24741264241247610

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Acute Vision Loss Following Intravitreal Ganciclovir Injection in Cytomegalovirus Retinitis: A Case ReportCase Report · 2026
2Suspected Retinal Toxicity After Multiple Intravitreal Ganciclovir Injections in a Patient of CMV Retinitis2024 · 9 citations
3Long-Term Outcomes of a Standardized 12-Week Oral Valganciclovir Treatment for PCR-Proven CMV Anterior Uveitis: A Retrospective Korean Cohort StudyCohort Study · 2026
4Presumed macular toxicity of high-dose intravitreal ganciclovir2024
5Long-term Efficacy of Oral Valganciclovir in Presumed Cytomegalovirus Unilateral Hypertensive Anterior Uveitis2024 · 6 citations